Company
Neusignal Therapeutics株式会社
Aiming for a future of overcoming dementia and contributing to humanity.
Also known as Neusignal Therapeutics, Inc
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- Neusignal Therapeutics, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Working on the development of NTX-083, a candidate compound for treating Alzheimer's disease (AD).
Funding snapshot
- Latest round
- Series B2026-06-30
Funding rounds
- Series B
- 2026-06-30
Loading relationship preview